# Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/neoadjuvant-and-adjuvant-pembrolizumab-in-resectable-locally-advanced-human/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Ravindra Uppaluri,Katie M. Campbell,Ann Marie Egloff,Paul Zolkind,Zachary L. Skidmore,Brian Nussenbaum,Randal C. Paniello,Jason T. Rich,Ryan S. Jackson,Patrik Pipkorn,Loren S. Michel,Jessica Ley,Peter Oppelt,Gavin P. Dunn,Erica K. Barnell,Nicholas C. Spies,Tianxiang Lin,Tiantian Li,David T. Mulder,Youstina Hanna,Iulia Cirlan,Trevor J. Pugh,Tenny Mudianto,Rachel Riley,Liye Zhou,Vickie Y. Jo,Matthew D. Stachler,Glenn J. Hanna,Jason Kass,Robert I. Haddad,Jonathan D. Schoenfeld,Evisa Gjini,Ana Lako,Wade L. Thorstad,Hiram A. Gay,Mackenzie Daly,Scott J. Rodig,Ian S. Hagemann,Dorina Kallogjeri,Jay F. Piccirillo,Rebecca D. Chernock,Malachi Griffith,Obi L. Griffith,Douglas R. Adkins |
| Citations | 369 |
| DOI | 10.1158/1078-0432.ccr-20-1695 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/7547532 |
| OpenAlex ID | https://openalex.org/W3042708039 |
| PMID | 32665297 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Dorina Kallogjeri](https://scholariq.org/researchers/dorina-kallogjeri/)
- [Jay F. Piccirillo](https://scholariq.org/researchers/jay-f-piccirillo/)

## Paper journal

- [Clinical Cancer Research](https://scholariq.org/journals/clinical-cancer-research/)

## Paper primary topic

- [Head and Neck Cancer Studies](https://scholariq.org/topics/head-and-neck-cancer-studies/)

## Paper topics

- [Head and Neck Cancer Studies](https://scholariq.org/topics/head-and-neck-cancer-studies/)
- [Head and Neck Surgical Oncology](https://scholariq.org/topics/head-and-neck-surgical-oncology/)
- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.